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3 RF Ablation: Targeting Painful 
Osteoid Osteomas 
Musculoskeletal interventional 
radiologists use a minimally 
invasive procedure to treat non- 
cancerous tumors found in many 
parts of the bone. 
O Bringing Ideas to Life 
In the Institute's Clinical Research 
Lab, skilled project coordinators 
provide physicians with tools for 
conducting a successful research 
protocol. 
10 Uterine Fibroid Embolization 
A uterus-sparing procedure has an 
impressive success rate for treating 
severe symptomatic fibroids that 
affect one in four women in the 
United States. 
ON THE COVER Michael Darcy, MD, leads a team of 
interventional radiologists who provide an alternative 
to hysterectomy for women with uterine fibroids. 
Photograph by Tim Parker. 
20 Lilliputian Particles 
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ceuticals via nanoparticles be the 
next advance in imaging technology? 
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with medical students and radiology 
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NINDS funds stroke research center 
As program director and principal investigator, Colin 
Derdeyn, MD, professor of radiology, of neurology, and of neu- 
rological surgery, received a $9.3 million grant from the National 
Institute of Neurological Disorders and Stroke (NINDS)—a 
part of the National Institutes of Health (NIH)—to develop new 
methods for diagnosing and treating stroke. Provisions of the 
five-year grant allow for establishing a Specialized Program for 
Translational Research in Acute Stroke (SPOTRIAS) Center at 
Washington University Medical Center. The Medical Center's 
efficient, high-volume acute stroke treatment team and 
Mallinckrodt Institute's reputation as a leader in radiology were 
recognized as major strengths of their successful application. 
Co-investigators for the Washington University SPOTRIAS 
Center are from the following groups: 
• Department of Emergency Medicine—Larry Lewis, MD; David 
Tan, MD; Douglas Char, MD 
• Department of Neurology—Abdullah Nassief, MD; Jin-Moo Lee, 
MD, PhD; David Carpenter, MD; Allyson Zazulia, MD; Michael 
Diringer, MD; Mark Goldberg, MD 
• Department of Neurosurgery—Gregory Zipfel, MD; Ralph 
Dacey, MD; Robert Grubb, MD 
• Department of Pathology—Mark Watson, MD, PhD 
• Department of Radiology—Katie Vo, MD; Tom Videen, PhD 
• Division of Biostatistics—Philip Miller, PhD; Gina D'Angelo, 
PhD; Paul Thompson, PhD 
• Occupational Therapy Pr 
gram—Lisa Connor, PhD 
• University of North Carolina— 
William Powers, MD; Weili Lin, PhD. 
yfc 
In addition to Washington 
University in St. Louis, the following 
institutions comprise the SPOTRIAS 
research center network: Columbia 
University; Harvard University; 
University of California, Los Ange- 
les; University of California, San 
Diego; University of Cincinnati; 
University of Texas, Houston; and 
an NIH stroke treatment program 
in Washington, DC. 
M 
Welch (left) received a plaque commemorating the 
creation of the Welch Award from Robert Mach, PhD, I 
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creation of the 
Michael J. Welch 
Award, which will be 
given annually for 
significant contribu- 
tions to the field of 
radiopharmaceutical 
sciences. The first 
recipient will be announced at the 2009 SNM meeting. 
The award's namesake is a pioneer in the field of radio- 
pharmaceutical chemistry who specializes in the synthesis 
of new radioactive chemicals for medical imaging. Welch, 
professor of radiology, of chemistry, and of molecular biology 
and pharmacology, joined the Mallinckrodt Institute faculty 
in 1967 and was a member of the team that developed 
positron emission tomography in the early 1970s. 
Of note 
Carolyn Anderson, PhD, professor of radiology, of biochem- 
istry, and of chemistry, was elected vice president of the Society 
of Nuclear Medicine's Molecular Imaging Center (MICoE) of 
Excellence. She will assume the MICoE presidency in 2010. 
Colin Derdeyn, MD, professor of radiology, of neurology, and of 
neurological surgery, was elected president-elect of the Society >f 
Nevtrolnterventional Surgery. He will be appointed president of 
the Society in 2010. 
Bennett Greenspan, MD, instructor in radiology, was elected to 
two-year term as president of the Society of Nuclear Medicine's 
Academic Council. 
k*" 
In July of 2008, a Siemens Biograph 40 TruePoint™ PET (positron emission tomography)- 
CT (computed tomography) scanner was installed in the nuclear medicine area on the 
Barnes-Jewish Hospital north campus. The new scanner, an addition to the Siemens 
Biograph 2 already in place, offers faster scanning (20 slices per second), higher resolu- 
tion images, and the capability for newer services such as cardiac PET—which translates 
to more PET capacity and easier scheduling. Also installed in July was a Siemens Symbia 
TruePoint SPECT-CT scanner; the addition of computed tomography to a nuclear medicine 
camera aids in visualizing the body's anatomy. 
Marcus Kessler, MD, nuclear me 
cine chief resident, was appointt 
to a one-year term on the Magne 
Resonance Committee and the 
Diagnostics Committee of the So 
ety of Pediatric Radiology. 
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Your teenage 
son complains of 
pain in one leg, that if s 
keeping him up at night. 
Growing pains, you think, and tell him 
the pain will go away. Not necessarily. 
What he may be experiencing is an osteoid 
osteoma, a noncancerous bone-forming tumor 
that occurs most often in the long bone's of the lower 
extremities. The femur, or thighbone, is the most common 
location, although the tumor can occur in almost any bone— 
especially the bones of the hand and sometimes the lower spine. 
Regardless of the location, these tumors can be very painful. 
RADIOFREQUENCY ABLATION: 
forgeting Pain' UbltJUlU UbltJUIIIUi 
Osteoid osteomas occur 
when certain cells divide 
uncontrollably, forming 
a small, brownish-red, 
gritty mass partially 
comprised of bone. The 
growing tumor displaces 
healthy bone tissue with 
its abnormal, hard tissue. These 
growths generally emerge during 
the teenage years or early adulthood 
(ages 5 through 25), are found more 
often in males than in females (2:1 
ratio), and account for approximately 
10 percent of all benign tumors. 
The good news is the tumors typi- 
cally do not progress in size beyond 
a half inch in diameter, do not 
harm the bone, and do not become 
malignant. However, pain caused 
by the tumor can rob patients of 
sleep and comfort. 
"Osteoid tumors are found in 
many parts of the bone: the outer 
portion, near the surface under the 
periosteum fibrous coating; even in 
the medullary cavity inside the 
bone shaft where marrow is 
stored," says Louis Gilula, MD, a 
musculoskeletal interventional 
radiologist at Mallinckrodt Institute. 
"The lesion itself is an inflammatory 
mixture created by the pressure 
of the tumor and the chemicals 
it forms." 
SYMPTOMS 
Depending on its location, 
the osteoma can have different 
symptoms: 
Dull or sharp pain that worsens 
at night 
Pain usually relieved by aspirin 
or other anti-inflammatory drugs 
Limping 
Painful scoliosis or muscle 
spasms, and other nerve 
symptoms like sciatica 
(when the tumor is in 
the spine) 
Muscle atrophy from not 
using the limb to avoid pain. 
Gilula says that typically 
these osteoid osteomas 
occur as one tumor unilater- 
ally, a characteristic that 
distinguishes them from the 
growing pains of youth, 
which tend to be bilateral. 
23-YEAR-OLD WOMAN WITH AN 
OSTEOID OSTEOMA 
Left, top: Arrow points to central lucent nidus 
(dark area) inside the femur. 
Left, bottom: Biopsy needle shown just 
above the nidus (arrow) prior to radiofre- 
quency ablation treatment. 
"Typically, they occur in one spot 
and rarely recur," he says. "The 
tumors might—but rarely—go 
away, within 36 months on average, 
without any treatment. However, 
because of the associated pain, 
patients generally don't want to 
wait. No one knows why these 
growths develop. Generally the 
bone is not damaged, unless the 
tumors occur on or near a growth 
plate, which could cause bone 
deformity because of the mass. 
The decision to treat, in most 
cases, is based on the patient's 
level of pain." 
DIAGNOSIS 
Diagnosis may be made by 
using one—or a combination— 
of the following tests: 
Xrays 
• Computed tomography 
Magnetic resonance imaging 
Fluoroscopy 
Bone scan 
Complete blood count 
Blood test. 
Initial diagnosis is usually 
made by X ray, which can detect 
the bony growth of the tumor. "We 
want to locate the radiolucent nidus, 
or center of the osteoma," says 
Gilula. "The growth is usually a 
round shape, but it may be oblong, 
conforming to some bony structure. 
Once the diagnosis is made, the 
condition can be treated." 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
PERCUTANEOUS RF ABLATION 
Traditionally, an osteoid 
osteoma was surgically removed 
by an orthopaedic surgeon. But 
musculoskeletal interventional 
radiologists—like Gilula and Daniel 
Wessell, MD, PhD, instructor in 
radiology in Mallinckrodt Insti- 
tute's Musculoskeletal Radiology 
section—are using a minimally 
invasive procedure called percuta- 
neous radiofrequency (RF) ablation. 
Gilula, a professor of radiology, 
of orthopaedic surgery, and of 
plastic and reconstructive surgery, 
has been using percutaneous RF 
ablation to treat these noncancerous 
tumors since 1997 and receives 
patient referrals from a wide 
geographic area. 
While the patient is under 
general anesthesia or deep conscious 
sedation, the radiologist uses fluo- 
roscopy or computed tomography 
to locate the nidus. Then a small 
hole is made into the nidus so the 
tumor can be biopsied. Next, a 
radiofrequency is sent through a 
needle that is inserted into the cen- 
ter of the lesion. The radiofre- 
quency generates heat —which is 
increased to 90 degrees Centigrade— 
that kills the tumor cells. 
ouis Gilula, MD, 
in a sixth-floor 
reading room in 
the Center for 
Advanced Medicine. 
After allowing time for 
recovery from the anesthesia, 
most patients go home the same 
day. The pain is usually gone by 
the day following the RF ablation, 
and regular activities can be 
resumed. After the procedure, the 
nidus gradually fills in the bone, 
which usually is thickened around 
the lesion and is even stronger than 
normal; stress on the bone is not an 
issue. The exception, says Gilula, 
is for triathletes whose combina- 
tion of activities puts undue stress 
on their joints. For these patients, 
Gilula recommends no training 
for six weeks. HI 
Editor's Note: Physicians who have questions about 
percutaneous RF ablation or want to refer a patient 
may call (314)362-2825. 
Daniel Wessell, 
MD, PhD, in the 
fluoroscopy room 
on Mallinckrodt 
Institute's third floor. 
TREATMENT ALTERNATIVES 
raping the tumor from the bone, using 
nstrument called a curette. Donor bone tissue or 
other materials are used to pack the cavity resulting from 
the curettaqe. 
1
 En bloc resection: gressive resection of the tumor, 
I removal of a block of bone 
... tumor and allowing for wide margins of 
healthy tissue. This approach is typically unnecessary in 
osteoid osteomas but was the treatment of choice prior 
to RF ablation. More often, when pain interferes 
with daily activity, RF ablation of the tumor is the 
treatment of choice. 
1
 Internal fixatioi 
the bone. 
. .(lowing en bloc excision of the 
ds or pins are used to support 
1
 Surgery: iuses, surgery may be the best 
i iur lesions close to the spinal cord or in 
. ry small bones close to the skin of the 
wrist bones. 






by Amy Thomas, MD, FAAP 
In a workday packed from start to finish with clinical duties, acade- 
mic radiologists have limited time for medical research. Though 
many have the vision necessary to improve the future of health and 
medicine, the process of running a clinical research study can be a 
daunting task. Even the most industrious physician is challenged to 
find study participants, coordinate detailed research protocols, 
monitor patients, and engage in all of the additional tasks required 
to conduct a valid clinical trial. 
But at Washington University 
in St. Louis, one of the 
world's largest academic 
research centers, physi- 
cians conducting clinical 
investigations that involve imaging 
can turn to a team skilled in the 
technical aspects of designing and 
executing a successful research 
protocol. Mallinckrodt Institute of 
Radiology's Clinical Research 
Laboratory (CRL) is a full-service 
project coordination group whose 
mission is to assist in any step of 
the research process. 
Led by Jeffrey Brown, MD; 
Shelly Meese; and Robin Haver- 
man, the CRL has grown since 1997 
from a small group of five to what 
is now a staff of 21 research spe- 
cialists readily available to assist 
clinicians with imaging research. 
The CRL provides many services 
that are essential to running a clinical 
research trial such as participant 
recruitment, obtaining patients' 
vital signs, laboratory tests and 
ECGs, image transfer and data 
entry. The CRL also helps principal 
investigators to identify appropriate 
funding opportunities for a project, 
prepare grant proposals, and prepare 
Institutional Review Board (IRB) 
applications. Research physicians 
are often pressed to find time for 
these duties, and guidance from 
highly qualified and experienced 
members of the CRL ensures that 
these processes run smoothly, 
without interrupting doctors' busy 
clinical schedules and giving them 
more time to focus on the scientific 
aspects of research. 
Getting projects off the ground 
At the earliest stages of 
research, the CRL plays a critical 
role in development by finding 
financial sponsors and submitting 
grant proposals. Shelly Meese, MHA, 
CRA, assistant director of the CRL, 
is well-versed in locating potential 
funding opportunities for imaging 
research. Combining a scientific 
background with a thorough knowl- 
edge of how and where to obtain 
funding dollars, Meese is dedicated 
to making the best match between 
a clinician and a research sponsor. 
The CRL staff also finds suitable 
principal investigators when 
approached by industry or agencies 
such as the National Institutes of 
Health. Once the match is made, 
members of the CRL are committed 
Ruth Holdener, RT(R), prepares (or a patient's computed tomography 
scan in the Center (or Clinical Imaging Research. 
Ready for the Institutional 
Review Board 
Before a research study can 
begin, special care must be taken 
to ensure participants' rights are 
protected and that they continue to 
receive appropriate medical care. 
In order to protect the welfare of 
research participants, the Food and 
The CRL provides many services that are essential 
to running a clinical research trial... 
Jeffrey Brown, WD 
to smoothing the process 
of grant submission by 
preparing and reviewing 
biographical sketches, 
resource and environ- 
ment information, letters 
of collaboration, IRB 
approvals, and budget 
justifications. They work 
closely with faculty on 
research design, editing 
and advising on the vari- 
ous sections throughout 
each step of the process 
and allowing more 
time for the clinician 
to concentrate on the 
medical science of the 
grant proposal. 
Drug Administration requires IRB 
approval for all biomedical 
research involving humans. The 
CRL staff has years of experience 
in assisting investigators in the 
preparation of a successful IRB 
application. They also help investi- 
gators to prepare for periodic IRB 
reviews of ongoing research, 
ensuring that protocols and related 
materials—informed consent 
documents and investigator 
brochures— are up to date and 
meet or exceed the review 
board standards. 
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,, Bringing 
ideas to life 
The CRL Staff 
•Darlene Bird, RT(R) (M), clinical 
research specialist 
•Jeffrey Brown, MD, director 
•Angela Campbell, RT(R) (M), 
clinical research specialist 
•Lora Gallagher, clinical research 
coordinator 
•Ellen Haenni, research secretary 
•Robin Haverman, manager 
•Ruth Holdener, RT(R), clinical 
research coordinator 
•Eileen Jacobs, RT(R) (M), 
clinical research coordinator 
•Shelly Meese, MHA, CRA, 
assistant director 
•Jill Neu, RT(R), clinical research 
coordinator 
•JoAnn Nevilles, research assistant 
•Patty Nieters, RN, BSN, clinical 
nurse coordinator 
•Leslie Rickard, grant assistant 
■Patty Rueweler, regulatory 
coordinator 
•Linda Schimmoeller, RN, BSN, CCRC, 
clinical research specialist 
■Mandie Street, RT(R), clinical 
research coordinator 
-Kathy Taylor, clinical research 
coordinator 
•Jeanine Wade, RT(R), clinical 
research coordinator 
•Rochelle Williams, data assistant 
(Left to right) Jeanine Wade, RT(R); Lora Gallagher; 
and Jill Neu, RT(R), with Marilyn Siegel, MD, a lead 
radiologist for IRAT. 
Finding the right people 
Once a project is approved, 
CRL staff identifies and screens 
potential research participants. 
Diligent and qualified CRL team 
members interact with potential 
study participants, educating them 
about the goals of the study and 
Mastering a large-scale challenge 
The NLST 
Services provided by the CRL 
have been particularly useful for 
Washington University School of 
Medicine's participation in the 
National Lung Screening Trial 
(NLST), sponsored by the National 
CRL staff has carried out all aspects of the study. 
addressing any questions or concerns 
they might have. This educational 
process helps potential study sub- 
jects to make an informed decision 
about whether to participate. 
Statistical support 
Statistical consultation is 
encouraged in the early phases 
of project development in order to 
assure appropriate study design, 
data collection, and data analysis. 
Charles Hildebolt, DDS, PhD, 
professor of radiology, and 
Thomas Pilgram, PhD, instructor 
in radiology, are available to 
provide statistical support to the 
diagnostic radiology faculty. 
i 1 I 
Cancer Institute (NCI). The NLST 
is an ongoing multicenter study 
designed to compare lung cancer 
mortality rates in smokers 
screened for lung cancer by chest 
X ray or computed tomography. At 
the Washington University site, the 
CRL staff has carried out all 
aspects of the study, including 
patient recruitment and enroll- 
ment, preparation of images for 
viewing, computerized data entry, 
and tracking participant health sta- 
tus. Since the study's launch in 
2002, nearly 3,800 participants 
were recruited at the Washington 
University site. 
David Gierada, MD 
David Gierada, MD, associate 
professor of radiology and co-prin- 
cipal investigator for the Washing- 
ton University NLST site, finds the 
CRL staff to be an invaluable asset: 
"A trial of the size and complexity 
of the NLST requires considerable 
skill, organization, and coordina- 
tion, so the performance of the 
CRL has been truly impressive. 
This has involved efforts of numer- 
ous study coordinators, nurses, as 
well as data entry and office sup- 
port staff, working in conjunction 
with radiologists and designates of 
the NCI overseeing the trial. In the 
NLST and other clinical imaging 
studies, having study coordinators 
with a radiology background 
ensures the technical standards of 
imaging protocols are met and opti- 
mal image quality is maintained for 
scientific purposes." 
The NLST is now closed to 
enrollment, but the CRL will con- 
tinue to be involved in patient fol- 
low-up and retention until its 
expected completion in 2011. 
I RAT 
The CRL also works closely 
with the Imaging Response Assess- 
ment Team (IRAT) led by Barry 
Siegel, MD, professor of radiology 
and of medicine and chief of 
Mallinckrodt Institute's Division 
of Nuclear Medicine. IRAT, also 
funded by the NCI through the 
Siteman Cancer Center, is a shared 
resource designed to promote 
collaboration between radiologists 
and oncologists during early stages 
of clinical trials, when imaging 
could predict clinical outcome. 
Marilyn Siegel, MD, professor 
of radiology and of pediatrics and 
the lead radiologist for conventional 
"One of our greatest advan- 
tages is that members of the CRL 
are intimately familiar with all 
imaging modalities, including com- 
puted tomography, magnetic reso- 
nance imaging, ultrasound, and 
mammography," says Robin Haver- 
man, who directs the clinical 
research staff. "Physicians con- 
ducting research involving any type 
of imaging can benefit immensely 
from services provided by the CRL 
and can be assured their projects 
are in qualified hands." 
"With demanding clinical com- 
mitments, the diagnostic radiology 
faculty has limited time to develop 
research, so they seek resources 
"One of our greatest advantages is that members of the 
CRL are intimately familiar with all imaging modalities..." 
imaging studies, heads a team of 
six dedicated IRAT radiologists 
who perform all measurements of 
tumor response to the treatment 
under investigation, ensuring 
consistency within a study. 
The CRL coordinators monitor 
all incoming requests, schedule 
and prepare images for review, 
and track all images and results, 
so the IRAT radiologist can 
concentrate exclusively on 
interpreting exams. 
Expanding their focus 
The CRL, although still 
primarily focused on working 
with radiologists, is now assist- 
ing principal investigators in 
other departments with imaging- 
related research. In most cases, 
a recommendation is made 
to include a radiology co-investi- 
gator to provide technical and 
clinical support. 
from the CRL," adds Meese. "Our 
role is to do all we can to help 
radiology faculty succeed. If they 
succeed—then we do." EH 
Patty Nieters, RN, is working with Suresh Vedanthatn, MD, the 
national principal investigator for a multicenter, NIH-funded study on the 
aggressive treatment of deep vein thrombosis (blood clots in the leg). 




A Uterus-Sparing Alternative for 
Treating Fibroids 
An estimated 70 percent of all women between the ages of 35 
and 60 have uterine fibroids; one in four women in the United 
States has symptomatic fibroids severe enough to require treat- 
ment. Over 600,000 hysterectomies are done each year—many 
of them for fibroid symptoms—at a cost of $5 billion. But there 
is a cost-effective alternative to hysterectomy and its attendant 
complications: uterine fibroid embolization (UFE), sometimes 
called uterine artery embolization (UAE). Over 100,000 UFEs 
have been performed worldwide with an enviably low complica- 
tion rate.  UAE has been used since the 1990s for emergency 
embolization for postpartum hemorrhage or to stabilize bleeding 
of a tumor prior to surgery. 
by Mary Jo Blackwood, UN, MPH, CHES 
At Mallinckrodt Institute of 
Radiology (MIR), Michael Darcy, 
MD, leads a team of interventional 
radiologists who collectively 
have decades of experience with 
UFE. "We believe there is a large 
population of women who could be 
successfully treated with this pro- 
cedure, but it is often overlooked 
as an option due to a general lack 
of awareness among the patients 
and their doctors," he says. "We 
strive to provide our patients with 
information and education on the 
procedure and other alternatives so 
they can make an informed choice. 
Lynn Hoese, a registered nurse on 
our team, excels in working with 
the patients and their families to 
provide procedure-related education 
and support." 
Nassir Siddiqi, MD, assistant 
professor of radiology, has been 
performing UFE for more than 
seven years with excellent results. 
For patients concerned about 
cutting off the blood supply to the 
uterus, he explains that the uterus 
"We believe there is a large population of women who 
could be successfully treated with this procedure, but 
it is often overlooked as an option due to a general lack 
of awareness among the patients and their doctors..." 
How UFE Works 
The patient must fast overnight. 
During the procedure—which 
takes about an hour and is done 
in the interventional radiology 
suite—the patient receives a local 
anesthetic. Then, a catheter (a thin 
tube) is passed into an artery in the 
groin and threaded into the uterine 
arteries where tiny embolic particles— 
about the size of grains of sand— 
are released. Riding along with the 
blood flow, these particles become 
lodged in the tiny arterioles feeding 
the fibroids and uterus, blocking 
the blood supply. If the uterus' 
blood supply is removed, it draws 
on other vessels for a blood source 
and totally recovers within a couple 
of days. Fibroids, however, quickly 
starve to death when deprived of 
their blood supply, stop producing 
excessive bleeding, and become 
soft and spongy, taking the pres- 
sure off adjacent organs. Over time, 
the fibroids shrink to 50 percent or 
more in size. 
Left: Selective injections into a uterine artery with 
a large hypervascular fibroid 
is a resilient organ with the ability 
to withstand periods of blood flow 
deprivation: "During childbirth, 
for example, the uterus cuts off its 
own blood supply, while detaching 
the placenta, to keep the woman 
from bleeding to death. Nature 
designed it very well." 
QVMPTn Uterine fibroid 
symptoms 
• Heavy, prolonged 
menstrual flow 
• Unusual monthly bleeding, 
sometimes with clotting 
• Back and leg pain 
• Pelvic pressure and pain 
• Bloating and constipation 
caused by pressure on bowel 
• Frequent urination caused 
by pressure on bladder 
• Enlarged abdomen. 
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UT Uterine Fibroid 
Embolization 
1TX F T JFTC Regaining quality of life 
"When I was having such heavy cramping and bleeding from my 
fibroids, I thought hysterectomy was my only option I wouldn't have 
thought of UFE, but my gynecologist brought it up, showed me a pamphlet 
on it, and gave me Doctor Darcy's name, explaining that the procedure is 
done by an interventional radiologist," 
Karen Wehmeyer had a magnetic resonance scan prior to her appointment 
with Darcy, who showed her the films and mapped the route he would use to 
do the embolization. He also laid out her options, the pros and cons, so that she 
knew what to expect every step of the way. Wehmeyer gave Lynn Hoese, Darcy's 
nurse, high marks for her explanation of the procedure and what to expect. 
"I had IV [intravenous] sedation, and I went into the operating room awake 
but relaxed. The anesthesiologist, the nurse, and Doctor Darcy talked to me 
throughout the procedure, which took about an hour. They explained every- 
thing they were doing and included me in the conversation. I felt like I was in 
very competent hands." 
Wehmeyer stayed overnight in the hospital so her pain medication could 
be regulated. A pain pump was connected to an IV during the procedure and 
when the cramping started, she understood how to use it and was able to get 
relief from the pain. She went home the next morning, with a supply of oral 
pain medications. The pills managed the pain adequately and after two days, 
she didn't need them. 
"I took a week off from work to give my body time to recover, but after 
that, I was cleaning house and really wanted to get back to work. Two days 
after the procedure, I went to my daughter's dance competition and climbed 
to the top of the bleachers in the gym with no problem," she says. 
Her real excitement, though, is the relief from her symptoms. "After the 
procedure, I had a very scant two-day period and then didn't another one for 
three months. The periods I've had since then have been extremely light. I have 
recommended this procedure and Doctor Darcy's team to all of my friends. 
There is really no recovery as compared to abdominal surgery, so I got my life 
back quickly." 
Left: Aortogram post-embolization, with no 
significant perfusion of the fibroid 
Says Siddiqi, "UFE has many 
advantages over hysterectomy: It 
is minimally invasive. The tiny nick 
in the groin leaves no scar, so it's a 
good cosmetic result. We use thin 
catheters to access the arteries 
supplying the uterus. No general 
anesthesia is involved, and patients 
are ambulatory in six hours or less. 
They resume oral intake shortly 
after the procedure and generally 
stay one night in the hospital, so 
we can control any pain." 
"The fibroids start dying 
immediately after UFE is com- 
pleted. The release of chemicals 
from the dying fibroids into the 
systemic circulation causes some 
cramping. The cramping may be 
initially severe but is easily con- 
trolled by pain medicines given 
intravenously in the hospital and 
then oral medications for a couple 
of days," Siddiqi adds. "The proce- 
dure is more cost-effective than a 
hysterectomy, is need only once in 
the majority of patients, and most 
patients are back to work within a 
week or so versus six weeks with a 
hysterectomy. Most patients have 
satisfactory resolution of symptoms 
with this procedure." 
The success rate of UFE is 
impressive: 90 percent when the 
predominant symptom is heavy 
bleeding; 85 percent if the main 
symptom is pressure and bulk. For 
women who want to have children, 
UFE spares the uterus. "However, 
there is not enough data to claim 
that fertility is not affected. There 
is a small chance that UFE will 
affect the ovaries because of tiny 
connections between the ovaries 
and uterus and blocking the arteries 
that feed the ovaries. It can happen 
in up to ten percent of women, 
more often in patients over the age 
of forty five," says Siddiqi. "If a 
woman wants to become pregnant, 
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(Left to right, clockwise): doctors Michael Darcy, Naganathan Mani, Darryl Zuckerman, Nael Saad, Nasir Siddiqi, and Jennifer Gould 
she may want to consider hor- 
monal therapy or myomectomy, an 
invasive surgical procedure that 
removes individual fibroids directly." 
However, results of alternative 
therapies are mixed: The effects of 
hormonal therapy are temporary, 
and symptoms usually recur after 
hormonal withdrawal. There are 
40,000 myomectomies done annu- 
ally, but Siddiqi cautions that it's an 
aggressive, invasive procedure— 
and sometimes the fibroids 
"The procedure is 
more cost-effective 
than a hysterectomy..." 
removed might not be the ones 
causing the symptoms. The surgery 
also leaves areas of weakness and 
scarring in the uterus that poten- 
tially could cause complications 
during childbirth. 
L1 A / 
Uterine Fibroid Facts  ^^^^^^^^^^— 
• Every 10 minutes, 12 hysterectomies are performed in the United States. 
• The majority of hysterectomies performed are due to the presence of 
uterine fibroids. 
• 37 percent of all women undergo hysterectomy by age 60. 
• African American women are 2 to 3 times more likely to have symptomatic 
uterine fibroids, typically at a younger age than other women with 
uterine fibroids. 
• Average age range for fibroids to become symptomatic is 
35 to 50 years. 
• Obesity is associated with the presence of uterine fibroids. 
• Recent research has shown some protective value [reduced 
incidence of uterine fibroids) to the consumption of green 
vegetables, fruit, and fish 
• Fibroids often grow rapidly during pregnancy when hormone 
levels are elevated and shrink after menopause when hormone 
levels decrease. 
Source: National Uterine Fibroids Foundation website: www.nuff.org/health.htm 
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Embolization 
Lynn Hoese, RN, provides procedure-related informa- 
tion to patients and their families. 
Appropriateness of UFE 
"Not every woman with pelvic 
pain and excessive bleeding has 
fibroids. MIR interventional radiol- 
ogists personally evaluate the patients 
during a clinic consult and obtain a 
magnetic resonance scan to make 
sure the fibroids are of the type and 
size that could be causing symptoms," 
says Darcy, professor of radiology. 
"Contrary to some misconception, 
most IR [interventional radiology] 
practices follow a clinical model of 
patient care: obtaining a patient's 
medical history; conducting a phys- 
ical exam; arranging for required 
labs and procedures, admissions, 
and pre-certifications; and providing 
extensive patient education, includ- 
ing a discussion of the risks, benefits, 
and alternatives of the procedure. 
We provide complete patient care, 
including follow-up care after the 
procedure in conjunction with the 
referring physician." 
Could a fibroid really be can- 
cerous? Siddiqi explains that the 
MIR interventional radiologists 
make an extraordinary effort to 
address not only this issue but to 
assure that they are not dealing 
with other occult cancers of the 
uterus manifesting as bleeding. In 
As more information is publi- 
cized about the effectiveness of UFE, 
referrals continue to grow, and 
now Mallinckrodt Institute has the 
largest experience with UFE in 
the St. Louis Metro area. 
Editor's Note: To speak to a doctor or 
nurse about UFE, call (314)362-2375 or 
toll-free at 1-866-254-7237. EH 
"...We provide complete patient care, including 
follow-up care after the procedure in conjunction 
with the referring physician." 1 
addition to the extensive history 
and physical exam, patients must 
have had a normal Pap smear 
[Papanicolaou screening test for 
cervical cancer] within the last 
year. Patients above a certain age 
who have irregular bleeding are 
referred to their gynecologists for 
an endometrial biopsy. This, together 
with the magnetic resonance imag- 
ing (MRI) of the pelvis, can identify 
other problems, if present. After 
undergoing UFE, the patient has a 
follow-up appointment after a few 
weeks and at six months, when 
they will have a repeat MRI to con- 
firm all changes. All information is 
shared with the referring physician 
to ensure continuity of care. 
rpTJi A 1\/r 
The MIR Team 
Michael Darcy, MD 
Jennifer Gould, MD 
Lynn Hoese, RN 
Naganathan Mani, MD 
Nael Saad, MD 
Nassir Siddiqi, MD 
Darryl Zuckerman, MD 
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PUSHING BACK BOUNDARIES 
A St. Louis MRI scanner to be used in brain research in Argentina 
by Steve Kohler 
Out with the Old—the Siemens Visions MRI 
scanner was moved from the Imaging Center 




The indigenous Kolla people 
reside in the remote, 
mountainous plains of 
northwestern Argentina— 
more than 1,500 kilometers 
from Buenos Aires. They have no 
cars, few roads and, in many 
villages, only locally produced 
electricity. The train that once 
served the area stopped running 
15 years ago. As a result, if the 
Kolla develop serious illnesses, 
they often go untreated. With only 
six psychiatrists for the entire region 
of 650,000 people, mental illnesses 
are particularly underdiagnosed. 
But soon, a world-class diag- 
nostic imaging device—a magnetic 
resonance imaging (MRI) scanner— 
will be delivered into their midst. 
Getting it there required every bit 
of the collaborative spirit and 
tenacious purpose that characterize 
the endeavors of Mallinckrodt 
Institute of Radiology (MIR) and 
Washington University. 
THE SEED 
Three years ago, 
when MIR faculty began 
to contemplate the need 
for a new research scan- 
ner, they wanted it to be 
an addition, not a 
replacement. The East 
Building's existing scan- 
ner—a highly developed 
and well-tuned device— 
had been a "workhorse," 
according to Marcus 
Raichle, MD, professor 
of radiology, of neurology, and of 
neurobiology. Many projects were 
being conducted with it as the data 
collection device. 
So when space and budget 
constraints eventually made it clear 
that a new machine would have to 
replace the old one, sending the 
older scanner off for scrap seemed 
inappropriate and wasteful, Raichle 
Marcus Raichle, MD 
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Out with the Old—the scanner begins its long journey to a hospital in Argentina. 
says. Conversations soon began 
about how the machine might 
continue to be of service somewhere 
else. No one remembers the exact 
details, but during those discussions, 
Yvette Sheline, MD, professor of 
radiology and of psychiatry, men- 
tioned a project being conducted in 
Argentina by a colleague, Gabriel 
de Erausquin, MD, PhD, associate 
professor of psychiatry and of ... 
neurology, that involved investiga- 
tions into untreated schizophrenia. 
Eventually, de Erausquin was 
invited to make a presentation to 
the Mallinckrodt Institute committee 
about how a scanner could benefit 
his research. 
Thus began the saga of the first 
donation of such a device by a uni- 
versity to a drastically underserved 
region, a complex and layered 
puzzle that has called upon the 
talents of many people but espe- 
cially Thomas Conturo, MD, PhD, 
associate professor of radiology, 
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of physics, and of biomedical 
engineering. Displaying his nature 
as a scientist, Conturo calls the 
experience, "one big experiment." 
Instead of Petri dishes and DNA 
analysis, the tools in this experi- 
ment include U.S. Air Force C-17 
Globemaster flights to Argentina, 
carrying 14 huge crates plus the 
scanner's magnet—about 36,000 
pounds of equipment, including 
the 23,000-pound magnet. Given all 
that the MIR team learned, Conturo 
is convinced that the experiment 
now could be replicated. 
THE DELIVERY 
The size of the payload was 
just one of the project's complicat- 
ing factors. "It was an ambitious 
undertaking," Conturo says. Getting 
the magnet out of the scanner bay 
was the first challenge. Lots of help 
is available to install a newly pur- 
chased magnet, but the logistics 
and cost of disconnecting and 
removing this used one all fell 
to Washington University. Then it 
had to be trucked, boxed, and stored 
in such a way that it could 
be reassembled. 
»J». 
Above: Gabriel de 
Erausquin, MD, PhD 
Right: Thomas 






What was the 
value of the 
scanner? 
Who are the requirements for 
duty-free entry into Argentina?— 
required nine months. Then came 
the move itself. Trucking it to 
Miami for loading onto a container 
ship was ruled out because the 
cargo wouldn't fit under many 
highway overpasses. Departure via 
Chicago and the Great Lakes was 
no better, and a route via the 
In with the New—the scanner was then moved 
into Bay 3 on the first floor of the Imaging Center. 
They also knew that no ship- 
board container was big enough. 
At 105 inches high (or even 95 
inches if all possible parts were 
removed), the scanner's magnet 
would need an open-topped container, 
and U.S. Homeland Security requires 
sealed containers. So they proposed 
air transport. But no commercial 
plane flying to Argentina could haul 
such cargo. 
"They knew the legalities of getting 
through customs anywhere..." 
Mississippi River was not possible. 
There was talk of giving up, Con- 
turo and Raichle admit. 
Then, a chance meeting between 
Conturo and scanner transportation 
specialists at the Radiological 
Society of North America's annual 
meeting reinvigorated the project. 
"They were with the company that 
moved the Rolling Stones' rock- 
and-roll stage show to Russia," 
Conturo says. "They knew the 
legalities of getting through customs 
anywhere and regularly moved 
huge payloads." 
In with the New—the 3 Tesla Siemens Trio (a whole- 
body scanner) was hoisted onto metal tracks. 
That left only the military. While 
he was participating in a conference 
in Buenos Aires, de Erausquin 
learned from his collaborators that 
the U.S. Air Force routinely flies 
supplies to South America (known 
as a channel flight). But whom to 
contact? Raichle says he jokingly 
suggested calling the Pentagon by 
looking under "P" in the phone 
book—which turned out to be 
exactly what de Erausquin had 
done, only to learn that the correct 
people were in MIR's back yard at 
Scott Air Force Base in Illinois. 
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used in brain research in Argentina 
PUSHING BACK BOUNDARIES 
Fortuitously, the U.S. Air Force 
regularly runs a huge plane full of 
humanitarian supplies to South 
America. And "yes," they said, the 
scanner could go at no charge 
under the auspices of the U.S. 
Congressional Denton Amendment 
that allows donors to use space 
on U.S. military cargo aircraft to 
transport goods and equipment to 
countries in need. The Denton 
Program is run by the U.S. Agency 
for International Development 
(USAID); after application to the 
program, approval by the U.S. 
State Department, and months of 
coordination between USAID offi- 
cers and FULTRA (the foundation 
responsible for the project in 
Argentina), the scanner shipment 
was authorized and a transporta- 
tion solution was finally in place. 
That breakthrough, Conturo 
says, revealed the next layer of 
complications. The magnet had to 
be restrained on the plane to resist 
g-forces of 3.0 to 4.5g, so a structural 
engineering analysis had to be 
performed—which a U.S. Air 
Force engineer had to approve—in 
order to certify the cargo for airlift. 
Because the scanner is a precision 
device, chains can't simply be 
slung around it. Enter Washington 
University's machine shop and 
facilities management. The 
restraint system—consisting 
of a steel frame, beams, 
wooden packing, and chains 
through steel rings—was 
designed (and is still evolving), 
in consultation 
with the Air 






the scanner from 
Buenos Aires, 
across the continent 
using military 
tank transports, 
into an appropriate 
location, and for 
obtaining installation and operation 
funding were facilitated by de 
Erausquin's established contacts 
with health agencies and the 
military in Argentina. 
THE REINCARNATION 
In its new life in Salta, the 
scanner will be a wellspring of 
health benefits to the Kolla people 
and others of their region, where 
no other MRI scanner exists. 
Installed in the Hospital Militar de 
Salta (Hospital Bedoya), it could 
perform perhaps 10 scans per day 
for as many as the next five to 10 
years, benefiting up to 36,000 
patients who otherwise would 
never have a MRI scan, Conturo 
Water cabinets to be loaded into the hold. 
says. Because ownership of the 
scanner was transferred to a free- 
standing institute operated under 
an agreement between two health- 
care foundations, all MRI imaging 
will be provided at cost to most 
users and free-of-charge to the 
Kolla population. 
The scanner also adds an impor- 
tant layer to de Erausquin's research. 
Until now, his investigations into 
untreated chronic schizophrenia in 
the region have progressed without 
a sophisticated imaging component. 
Scott Air Force personnel loaded the water cabinets 
onto a flatbed for transport to the cargo plane. 
"The lack of advanced imaging has 
been a limitation on the work," 
de Erausquin says. It's a "core 
need" in his attempt to get a handle 
on the cascade of events behind 
schizophrenia. 
Mission accomplished: The water cabinets are secured 
in the plane's hold and are ready to be flown to 
South America. 
the disease. Through diagnosis, 
clinical care, and research involving 
this population, it may finally be 
possible, de Erausquin says, to 
ascertain whether any changes in 
the brain, detected by MRI imaging, 
are attributable to the disorder or 
to drug treatment. The research in 
the Andes ultimately may resolve 
long-running uncertainty and dis- 
agreement among researchers 
worldwide about whether certain 
observations in schizophrenia are 
truly a part of the disorder or are 
"It was an ambitious undertaking..." 
The precise neurophysiological 
images the scanner produces will 
assist in separating the clinical 
manifestations of schizophrenia 
according to their potential 
causes—genetics, damage to 
particular neurons during develop- 
ment, and others. The comparison 
of specific changes in behavior and 
movement with changes in brain 
physiology that the scanner makes 
observable will be invaluable to 
the research, he says. 
Because schizophrenia among 
the Kolla so frequently goes undiag- 
nosed and untreated, the newly 
diagnosed, newly treated patients 
in these studies will be relatively 
unaffected by powerful pharmaceu- 
tical therapy usually prescribed for 
actually attributable to the side 
effects of pharmaceutical treatments. 
Literally pushing back bound- 
aries—from St. Louis to the Puna 
de Atacama range of the Andes— 
Mallinckrodt Institute faculty and 
their many colleagues kept at this 
project in the knowledge that 
their beloved old scanner could be 
of real benefit. With the device 
expected to be operational some- 
time in 2009, they will get to relish 
all of the ways in which that turns 
out to be true, from providing an 
accurate diagnosis of a single head 
injury that occurred 9,000 kilome- 
ters away to possibly putting to 
rest some of the most persistent 
questions in brain research. EM 
THE UNSUNG 
In addition to Raichle, Conturo, de 
Erausquin. Sheline, and Gilbert Jost, 
MD, director of Mallinckrodt Institute 
and head of the Department of Radiology, 
many people and organizations pitched 
in to make the donation of the scanner 
possible. Here are a few, with apologies 
to those overlooked. 
Washington University 
• John Kreitler, machine shop 
• Gary Maus, purchasing 
• Roy Van Hee, facilities management 
• Marion Harris, Center for Clinical 
Imaging Research at Mallinckrodt 
Institute 
Industry 
• Lee Wyman, Ben-Hur Construction 
St. Louis 
• Grace Warner, Rock-It-Cargo 
transport service 
• Jonathan Wood, Siemens Medical 
Solutions USA, Inc. 
• David Purdy, PhD, Siemens Medical 
Solutions USA, Inc. 
• Siemens Argentina 
• Mario Gomez, PhD, structural 
engineering consultant, St. Louis 
Military 
• Technical Sergeant Charles Rager 
and colleagues, 375 Logistics Readi- 
ness Squadron air transportation 
specialists, Scott Air Force Base, 
Illinois 
• Ken Hundemer and Mike McAvoy, 
Denton Program, Charleston Air 
Force Base, South Carolina 
• Eric Treadwell, Wright-Patterson 
Air Force Base, Ohio 
• Ejercito Argentino [the Argentinean 
Army) 
• Eliana Korin, U.S. Air Mobility 
Command, Argentina 
Foundations 
• USAID Denton Program 
• FULTRA Foundation, Argentina 
• FUSEA, Argentina 
I 
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cargo to deliver, you need a truck of the right size and configuration. Too small, and the payload won't fit. Too big, and overpasses, 
tight turns, and other obstacles restrict your destination. 
The problem is essentially the same for researchers 
exploring the delivery of imaging agents and therapeutic 
radiation or pharmaceuticals using nanoparticles. It may 
be counterintuitive to think of a submicroscopic particle 
about the size of a single virus virion as a truck, but in 
many ways, the analogy holds, according to Michael 
Welch, PhD, professor of radiology, of chemistry, and of 
molecular biology and pharmacology. 
Small animal projection positron emission tomography (PET) image at 4 hours: 
hind limb ischemia in mouse model using control-comb nanoparticle (NP), shown on 
right within red circle, and avS3 targeted-comb NP, shown on left. Uptake of a^3 
targeted-comb was higher in the ischemic hind limb (shown on left) as compared to 
the control limb. 
What are 
nanoparticles? 
Though they are almost incom- 
prehensibly tiny delivery devices, 
nanoparticles nonetheless are 
larger than the small molecules 
"...there are adverse effects and risks to everything, 
and we want to reduce them as much as possible while 
we maximize the benefit." 
nanoparticles that are injected into 
the bloodstream can go to destina- 
tions that microparticles cannot. 
They also are not rapidly screened 
out of the system by the body's fil- 
ters, such as the lung and the spleen. 
Nanoparticles can be manufac- 
tured from many substances—inor- 
ganic particles are often forms of 
iron or gadolinium, a rare earth 
commonly used to enhance imag- 
ing, known broadly as contrast 
agents. Those small molecules can 
be manufactured to have, "one, 
maybe two functions—a targeting 
element and something that can be 
detected to make an image," Welch 
says. By contrast, nanoparticles 
can be "decorated with many small 
molecules" that enhance their func- 
tionality. And because they are 
only one-tenth to one one-hun- 
dredth the size of microparticles, 
mineral with magnetic properties. 
Those that Welch, associate direc- 
tor of oncologic imaging for Site- 
man Cancer Center, develops are 
organically based. They originate in 
the laboratory of Karen Wooley, 
PhD, professor of chemistry and of 
radiology, who says that her 
nanoparticles are similar in compo- 
sition to the Styrofoam™ in a 
throw-away coffee cup, which, 
believe it or not, is organically 
based. Others start as polyacrylic 
Crafting Organic Nanostructures with Well-defined Sizes. Shapes, Structures, and Properties: 
Robust nanoscale objects for fundamental studies and applications in nanomedicine 
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Michael Welch, PhD 
acid, akin to the absorptive filling 
in disposable diapers. Either way, 
their organic nature provides a 
measure of security against potential 
toxicity, Welch says. "Once they've 
done their work, they fall apart." 
Cardiac disease and cancer research 
Welch and Wooley have been 
exploring the potential for 
nanoparticles in imaging for six 
years, funded by a major grant 
from the Heart, Lung and Blood 
Institute of the National Institutes 
of Health. Mallinckrodt Institute of 
Radiology at Washington Univer- 
sity is one of only four centers in 
the nation named to develop nano 
agents for applications in cardiac 
disease. Lately, Welch and Wooley 
have been working to control the 
size, shape, flexibility, and compo- 
sition of the particles so they can 
be tailored to do precisely the work 
that the researchers want done. 
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By manufacturing nanoparti- 
cles with surface chemistries that 
react to water at known rates, the 
researchers can dictate the length 
of the nanoparticles' lives. That 
means, Welch says, that 
the life of a radioactive tag that's 
attached to a nanoparticle is able 
to be controlled—functional long 
enough to generate an image but 
degraded and cleared from the 
body quickly thereafter. By using 
the available surface to attach 
many such radiolabels, the image 
produced is brighter than what was 
possible previously, and a lower 
dosage gives a better diagnostic 
image. Lower dosages are desirable 
because they produce fewer 
adverse effects. 
Also instrumental in determin- 
ing the lifetime of the nanoparti- 
cles, Wooley says, is the size. Small 
versions, what she calls "stealth" 
particles, take longer to be 
detected and don't antagonize the 
body's defenses as quickly, so they 
survive longer. That control is 
important, Wooley says, particu- 
larly because "there are adverse 
effects and risks to everything, and 
we want to reduce them as much 
Wooley and Welch also attach 
targeting molecules to the surfaces 
of the nanoparticles to steer the 
complex precisely to a specified 
destination. Using antibodies, pep- 
tides, and ligands (molecules that 
recognize and bind to specific 
receptors), they have developed an 
array of clever systems for target- 
ing particular locations. For exam- 
ple, certain peptides recognize and 
bind to enzymes of the immune 
system that are up-regulated as 
part of the body's inflammatory 
response. Exploiting this activity 
provides the investigators with an 
effective way to make images of 
the inflammation that is character- 
istic of lung damage or acute vas- 
cular injury. "If you can see the 
"If you can see the inflammation and assess its extent, 
you may be able to guide therapy more successfully.55 
as possible while we maximize the 
benefit." Controversy exists, for 
example, over the safety of gadolin- 
ium nanoparticles, with some of 
the opinion that they can cause 
serious injury to the liver. 
I  Nanoparticles get their name from the prefix 
"nano," meaning one-billionth. Strictly speaking, 
they should then be a billionth of a meter in diameter or long dimension. 
That's 109 meters, if that helps. In fact, the group of particles classed as 
"nano" ranges from five to 100 nanometers in size, Wooley says. 
That's roughly the size of a virus particle, or virion, which is still not very 
instructive. So Wooley offers this image: In size, a nanoparticle is to an 
average human body as that human body is to the planet Earth. 
Or, try this: If you have a full head of hair and, instead of being as big as they 
are today, the individual hairs were the thickness of a single nanoparticle, 
iu'd appear completely bald to the human eye, the strands invisible. 
inflammation and assess its extent, 
you may be able to guide therapy 
more successfully," Welch says. 
In their work on heart disease, 
the researchers have devised meth- 
ods for targeting blood clots and 
atherosclerotic plaques, indicators 
of an impending heart attack that 
otherwise would be difficult to 
diagnose until the event has 
occurred. Welch believes nanopar- 
ticle imaging may make it possible 
to determine the extent of pre- 
heart attack cardiac disease so that 
clinicians can intervene before dis- 
aster strikes.. 
Cancer cells also express par- 
ticular receptor proteins on their 
surfaces and inside cells. And by 
isolating the ligands that bind to 
those receptors and making them a 
part of the nanoparticle's exposed 
cargo, Welch and Wooley can send 
the little payloads to tumors. The 
delivery also can include proteins 
called cell permeation peptides— 
proteins that drag themselves 
through the cell wall, along with 
: 




Radiolabeled nanoparticles can be studied in mice, 
comparing three different particles with different 
stealth properties. 
whatever they are attached to. In 
this way, nanoparticles assembled 
to just the right size can be deliv- 
ered through the cell wall to targets 
residing within particular cells. 
Most recently, Wooley also has 
begun exploring the effects of the 
shape of nanoparticles on their 
behavior. "Our hypothesis is that 
shape is critically important, espe- 
cially in how nanoparticles traverse 
openings in vasculature," she says. 
Imaging application 
Welch's enthusiasm over the 
potential for nanoparticles springs 
primarily from the emerging capa- 
bility to adapt them to many forms 
of imaging. They can be made to 
carry miniscule radioactive pay- 
loads that show up on conventional 
computed tomography scanners. 
They also may be useful in magnetic 
resonance imaging applications to 
deliver contrast agents to precisely 
max 
mm 
defined targets. And 
work has begun on their 
use in visual imaging 
applications as optical 
I        probes to deliver fluores- 
cent agents—the light 
from these agents can be 
detected by a new gener- 
ation of scanners that 
will be able to "see" and 
then enhance what the 
eye cannot. 
Nanoparticles also 
hold promise as a means 
to transport therapeutic 
agents of several types. If 
they can deliver small 
molecules for imaging 
purposes, and there is 
room on the truck, then 
they also might be used 
to haul pharmaceuticals 
to carefully targeted dis- 
ease sites. By controlling distribution 
and dose, adverse effects might be 
mitigated. Welch says the same 
technique might be applied to deliv- 
ering radiotherapy to tumor sites. 
By using nanoparticles that release 
their radiation only when they have 
accurately reached a tumor, for 
example, the need to treat cancer 
by passing beams of radiation 
through nearby, healthy tissue 
could be reduced. And the potential 
exists for using them in gene ther- 
apy to replace defective genes or 
restore failing gene activity. 
It's this multifunctional aspect 
of nanoparticles and the precise 
control that researchers can exert 
over their behavior that make them 
especially promising for radiologists. 
Welch believes that nanoparticles 
have the potential to be the next 
big advance in imaging technology, 
a future in which fewer and smaller 
trucks will be guided precisely 
down the body's highways to do 
more work with reduced risks of 
adverse effects. EH 
A grant from the Heart.Lung and Blood 
Institute/National Institutes of Health 
funds research for developing nano 
agent applications in cardiac disease. 
• Samuel Achilefu, PhD, 
professor of radiology and 
of biochemistry and 
molecular biophysics 
• Carolyn Anderson, PhD, 
professor of radiology, of molecular 
biology and pharmacology, and 
of chemistry 
• Stephen Brody, MD, associate 
professor of medicine 
• Robert Gropler, MD, professor 
of radiology, of medicine, and of 
biomedical engineering 
» Michael Welch, PhD, professor 
of radiology, of chemistry, and of 
molecular biology and pharmacology 
» Pamela Woodard, MD, associate 
professor of radiology 
» Karen Wooley, PhD, professor 
of chemistry and of radiology 
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Taking MIR expertise 
/—^-i^^      \- \s*\ y"v     i^/^y/-» y-J Mallinckrodt Institute ofRadialogy (MIR) is internationally known 
111 I |— [ I     \s\ | for radiological expertise, compassionate patient care, state-of-the- 
V-X-1--1- L~-I—L.^^ -L v/l/Vvl» art technology, and innovative research. Providing physicians and 
other health professionals with the latest medical information is an integral part ofMIR's dedication to education. And it was in 
that spirit of sharing the latest radiology information that Nirvikar Dahiya, MD, research instructor in radiology, spearheaded 
the organization of two sessions of Continuing Medical Education (CME) in India, one course in Agra, the other in Coimbatore. 
The following is Dahiya's firsthand account of taking an MIR-based CME course on the road. 
The idea of sharing MIR exper- 
tise with radiologists and 
radiology residents in India 
was conceived at a noon conference 
in Scarpellino Auditorium. As I 
heard the lectures given by MIR 
faculty, I wished that residents in 
my native India could be exposed 
to this high quality of training and 
education. I was actively involved 
in education and training programs 
in India and was involved in the 
management of an ultrasound 
training school for technologists 
and doctors in Coimbatore. 
On a CME trip to Thailand, I 
travelled with Sanjeev Bhalla, MD, 
associate professor of radiology, 
and Christine Menias, MD, associ- 
ate professor of radiology. During 
the trip, I proposed to them the 
idea of a CME course in India. 
Their enthusiasm to participate was 
the catalyst I had been waiting for. 
For the course to be truly 
effective, the Indian Radiology and 
Imaging Association (IRIA) had to 
be involved in the planning. Dr. N. 
Kulasekaran, president of IRIA, 
was very encouraging and support- 
ive. After much deliberation, we 
chose Agra as the CME course site. 
Agra is easily accessible from Delhi 
for international faculty, and it is 
the home of the Taj Mahal—a 
world renowned monument and a 
big attraction for delegates. Dr. 
Bhupendra Ahuja took on the 
responsibility of all local organiza- 
tion on behalf of the Uttar Pradesh 
state branch of IRIA. A team was 
assembled to coordinate the entire 
conference, and their efforts toward 
the success of the initiative cannot 
be overemphasized. 
Bhalla, Menias, and I were the 
final Mallinckrodt Institute faculty 
for this maiden attempt. The suc- 
cess of this CME would be the basis 
for an annual or a biannual event 
focusing on different areas of radi- 
ology. Thus, it was imperative to 
actively participate in the formations 
of tis course curriculum and selection 
of the faculty. 
We decided to focus on "Body 
Imaging" and a "Musculoskeletal 
Ultrasound Workshop" for this first 
course, which required multiple 
late night telephone calls and tele- 
conferences with the organizers in 
India. Flexibility was critical in 
multiple areas. We asked nationally 
known speakers from India to 
JRRENT IMAGING TREND 
L Clinical Update with Case Studies 
In Coimbatore, Dr. 
Murugan, the CME orga 
nizer, introduces doctor' 
Dahiya, Menias, and 
Bhalla. Murugan, who 
runs a state-of-the-art 
diagnostic facility 
in the region, visited 
Mallinckrodt Institute 
in 2007. 




cover magnetic resonance imaging 
and added faculty for the workshop 
related to musculoskeletal ultrasound. 
The CME in Agra was two days 
(August 2 and 3) of intense work— 
the faculty lectured to and answered 
questions from more than 150 resi- 
dents and junior radiologists 
attending the CME. The workshop 
received rave reviews. Everyone 
appreciated the quality of teaching. 
Positive feedback was put forth on 
how to conduct an even better 
CME and workshop in the future. 
We did get to see the Taj Mahal 
in Agra. The multiple pictures seen 
in brochures and travelogues do 
not do justice to the mausoleum's 
Below: (Left to right) Bhalla, Menias, and Dohiyo at 
the Taj Mahal in Agra—an internationally known 
mausoleum built during the reign of Mughal Emperor 
Shah Jahan in memory of his wife Mumtaz Mahal. 
Nirvikar Dahiya, MD, (at podium) speaking 
at the CME course in Agra 
majestic appeal in real time. 
After a brief stopover in 
Jaipur, we proceeded to 
Coimbatore, an industrial 
city in South India. On 
August 10, we conducted a 
one-day CME course, which 
focused on multidetector 
CT technology and its role 
in changing radiology man- 
agement, for the local radiologists 
and other physicians. We were 
pleasantly surprised by the enthusi- 
asm shown by the local students 
and physicians. 
Our basic idea for the CME 
course in India was to achieve 
"knowledge transfer" in a way that 
would contribute to the future of 
radiology on an international scale. 
While international conferences 
routinely achieve this goal, our 
concerted effort at the CME in 
India was to present the content 
in a manner that resonates with 
the excellence of the residency and 
fellowship training programs at 
Mallinckrodt Institute. To that 
effect, I think we succeeded and 
hope that our effort will motivate 
other distinguished faculty from 
Mallinckrodt Institute to partici- 
pate in similar CME programs in 
India in the future. 
—Nirvikar Dahiya, MD 
MIR faculty: CME Workshop, 
Agra, India 
Body Imaging: Newer Concepts, and "Hands- 
on" Workshop on Musculoskeletal Ultrasound 
ABDOMINAL IMAGING 
Nirvikar Dahiya, MD, "US and color Doppler 
in liver transplant." 
HRCT OF LUNGS 
Sanjeev Bhalla, MD, "HRCT Part 1: lines, 
nodules, cysts"; "HRCT Part 2: fibrosis, GGO 
& mosaic." 
GI IMAGING 
Christine Menias, MD, "MDCT of ischemic & 
GI bleeding"; "Virtual colonoscopy." 
Christine Menias, MD; Sanjeev Bhalla, MD; 
Nirvikar Dahiya, MD, "Interesting Mallinck- 
rodt Cases Session." 
IMAGING IN TRAUMA 
Sanjeev Bhalla, MD, "Trauma of the chest— 
Part 1: Great vessels and heart; Part 2: Non- 
vascular trauma." 
Christine Menias, MD, "CT of blunt abdominal 
CARDIO THORACIC IMAGING 
Sanjeev Bhalla, MD, "CT of mediastinum"; 
"Logical approach to congenital heart disease. 
Christine Menias, MD, "CT of acute vascular 
emergencies"; "PET CT body applications." 
MUSCULOSKELETAL ULTRASOUND 
Nirvikar Dahiya, MD, "Basic anatomy and 





•Role of multislice CT in chest diseases 
•Role of Cardiac CT in coronary artery disease 
•Role of multislice CT in abdominal 
disease/virtual colonoscopy 
•Dynamic musculoskeletal ultrasound— 
The perfect companion to MRI 
'Role of MRI in clinical practice— 
an overview. 
In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology are highlighted in boldface type. 
NEW FACULTY 
Catherine Appleton, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology. 
Xiang He, PhD, instructor 
in radiology, Division of 
Radiological Sciences. 
Cheryl Herman, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology. 
Jack Jennings, MD, PhD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology. 
Geetika Khanna, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology. 
Seung Kwon Kim, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology. 
Robert Pallow, MD, 
instructor in radiology, Divi- 
sion of Diagnostic Radiology. 
Nasir Siddiqi, MD, assistant 
professor of radiology, Divi- 
sion of Diagnostic Radiology. 
FIRST-YEAR 
FELLOWS  
Tara Anthes, MD, breast 
imaging clinical fellow, 
received an undergraduate 
degree from Brown University 
and a medical degree from 
the University of Washington. 
She completed additional 
training at Virginia Mason 
Medical Center and a diag- 
nostic radiology residency at 
Mallinckrodt Institute of 
Radiology. 
Truitt Balart, MD, abdomi- 
nal imaging clinical fellow, 
received an undergraduate 
degree from the University 
of Georgia and a medical 
degree from Louisiana State 
University. He completed 
additional training and a 
radiology residency at 
Louisiana State University 
Health Sciences Center. 
Samuel Chang, MD, body 
magnetic resonance imaging 
clinical fellow, received an 
undergraduate and a medical 
degree from Seoul National 
University. 
Patrick Cox, MD, PhD, 
diagnostic neuroradiology 
clinical fellow, received an 
undergraduate degree from 
Austin College and a medical/ 
doctoral degree from Baylor 
University. He completed 
additional training at 
Methodist Hospital/Indiana 
University. 
Henry Dalsania, MD, inter- 
ventional radiology clinical 
fellow, received an under- 
graduate degree from Drury 
College and a medical degree 
from Saint Louis University. 
Jennifer Demertzis, MD, 
musculoskeletal radiology 
clinical fellow, received an 
undergraduate degree from 
the University of Notre Dame 
and a medical degree from 
Emory University. She com- 
pleted additional training at 
Emory University and four 
years (chief resident, 2007- 
2008) of diagnostic radiology 
training at Mallinckrodt 
Institute of Radiology. 
Tejaswini Deshmukh, MD, 
pediatric radiology clinical 
fellow, received an under- 
graduate from Vivekananda 
Jr. College and a medical 
degree from Seth Gordhan- 
das Sunderdas Medical Col- 
lege/King Edward Memorial 
Hospital. 
Alexandra Georges, MD, 
musculoskeletal radiology 
clinical fellow, received an 
undergraduate degree from 
Johns Hopkins University 
and a medical degree from 
the University of Missouri, 
Columbia. She completed 
additional training and a 
radiology residency at Uni- 
versity Hospital and Clinics. 
Samuel Gibson, MD, 
diagnostic neuroradiology 
clinical fellow, received an 
undergraduate degree from 
Northwestern College and a 
medical degree from the 
University of Iowa. He com- 
pleted additional training at 
Tucson Medical Center and a 
radiology residency at Uni- 
versity Medical Center. 
Catherine Glynn, MD, 
breast imaging clinical fellow, 
received a medical degree 
from the National University 
of Ireland. 
Eric Hatfield, MD, body 
magnetic resonance imaging 
clinical fellow, received an 
undergraduate degree from 
the University of Notre 
Dame and a medical degree 
from Washington University 
in St. Louis., He completed 
additional training at St. 
Mary's Health Center and 
four years of diagnostic radi- 
ology training at Mallinck- 
rodt Institute of Radiology. 
Alok Jaju, MD, pediatric 
radiology clinical fellow, 
received an MBBS degree 
from Government Medical 
College and Hospital. He 
completed additional train- 
ing at Government Medical 
College and Hospital and at 
Lokmanya Tilak Municipal 
Medical College. 
Kartikeya Kantawala, MD, 
abdominal imaging clinical 
fellow, received an MBBS 
degree and a diploma in 
Medical Radio-diagnosis 
from Lokmanya Tilak Munic- 
ipal Medical College and a 
medical degree from the 
University of Seychelles. He 
completed additional training 
and a radiology residency at 
Lokmanya Tilak Medical 
College and Hospital and 
one year of nuclear medicine 
training at Mallinckrodt 
Institute of Radiology. 
Monica Kessi, MD, diag- 
nostic neuroradiology 
clinical fellow, received an 
undergraduate degree from 
the University of Portland 
and a medical degree from 
the Oregon Health and 
Science University. She coi 
pleted additional training a 
Legacy Emanuel Hospital 
and a radiology residency a 
Saint Louis University. 
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Jonathan Kraus, MD, 
musculoskeletal radiology 
clinical fellow, received an 
undergraduate degree from 
the University of Notre 
Dame and a medical degree 
from Wake Forest University. 
He completed additional 
training at the University of 
Alabama. 
Alan Lobo, MD, diagnostic 
neuroradiology clinical fel- 
low, received an undergradu- 
ate degree from Texas A&M 
University and a medical 
degree from Louisiana State 
University. He completed 
additional training and a 
radiology residency at Henry 
Ford Hospital. 
David Loy, MD, PhD, 
diagnostic neuroradiology 
clinical fellow, received an 
undergraduate degree, a 
medical degree, and a 
doctoral degree from the 
University of Louisville. He 
completed additional train- 
ing at the University of 
Louisville and four years 
of diagnostic radiology 
training at Mallinckrodt 
Institute of Radiology. 
Jose Maldonado, MD, car- 
diothoracic imaging clinical 
fellow, received an under- 
graduate degree from Tulane 
University and a medical 
degree from the University 
of Puerto Rico. He completed 
additional training and a 
radiology residency at the 
University Hospital, Univer- 
sity of Puerto Rico. 
Paolo Marciano, MD, PhD, 
interventional radiology 
clinical fellow, received an 
undergraduate degree, a 
medical degree, and a 
doctoral degree from the 
University of Pennsylvania. 
He completed additional 
training at the University 
of Pennsylvania and four 
years of diagnostic radiology 
training at Mallinckrodt 
Institute of Radiology. 
Christopher Murdock, 
DO, body magnetic reso- 
nance imaging clinical 
fellow, received an under- 
graduate degree from the 
University of Utah and a 
medical degree from Kansas 
City University of Medicine 
and Biosciences. He com- 
pleted additional training at 
Forest Park Hospital and a 
radiology residency at Saint 
Louis University. 
Amy Oberhelman, MD, 
diagnostic neuroradiology 
clinical fellow, received an 
undergraduate degree from 
Stanford University and a 
medical degree from Wash- 
ington University in St. Louis. 
She completed additional 
training at St. John's Mercy 
Medical Center and four 
years of diagnostic radiology 
training at Mallinckrodt 
Institute of Radiology. 
Rosana Ponisio, MD, diag- 
nostic neuroradiology clini- 
cal fellow, received a medical 
degree from the National 
University of La Plata. 
Monika Prost, MD, breast 
imaging clinical fellow, 
received a medical degree 
from Charles University. 
She completed additional 
training at the University of 
Missouri, Columbia Health 
Science Center. 
Steven Repka, MD, abdom- 
inal clinical fellow, received 
an undergraduate degree 
from Pennsylvania State Uni- 
versity and a medical degree 
from Temple University. He 
completed additional train- 
ing and a radiology residency 
at Western Pennsylvania 
Hospital. 
Patricia Richmond, MD, 
breast imaging clinical fellow, 
received an undergraduate 
degree from the University 
of California, Berkeley, and 
a medical degree from the 
University of California, San 
Francisco. She completed a 
transitional year at Forest 
Park Hospital and four years 
of diagnostic radiology train- 
ing at Mallinckrodt Institute 
of Radiology. 
Sara Rohr, MD, muscu- 
loskeletal radiology clinical 
fellow, received an under- 
graduate degree from 
Gustavus Adolphus College 
and a medical degree from 
the University of Iowa. She 
completed additional train- 
ing at Forest Park Hospital 
and four years (chief resident, 
2007-2008) of diagnostic 
radiology training at 
Mallinckrodt Institute of 
Radiology. 
Jonathan Sehy, MD, diag- 
nostic neuroradiology clinical 
fellow, received an under- 
graduate degree from the 
University of Illinois, Urbana- 
Champaign, and a medical 
degree from Washington 
University in St. Louis. He 
completed additional training 
at St. Vincent Hospital and 
four years of diagnostic radi- 
ology training at Mallinckrodt 
Institute of Radiology. 
Jennifer Sharp, MD, 
abdominal imaging clinical 
fellow, received an under- 
graduate from Washington 
University in St. Louis and a 
medical degree from the 
University of Illinois. 
Rakesh Varma, MBBS, 
interventional radiology 
clinical fellow, received an 
undergraduate degree from 
DG Ruparel College and a 
medical degree from Seth 
Gordhandas Sunderas Med- 
ical College/King Edward 
Memorial Hospital. He com- 
pleted additional training at 
Seth Gordhandas Sunderas 
Medical College/King 
Edward Memorial Hospital 
and at LTMMC & LTM 
General Hospital. 
Quan Vu, MD, muscu- 
loskeletal radiology clinical 
fellow, received an under- 
graduate degree from the 
University of Virginia and a 
medical degree from Emory 
University. He completed 
additional training at Caril- 
ion Health System and four 
years of diagnostic radiology 
training at Mallinckrodt 
Institute of Radiology. 
Ramana Yedavalli, MD, 
interventional radiology clin- 
ical fellow, received an 
undergraduate degree from 
Northwestern University and 
a medical degree from the 
University of Illinois. He 
completed additional train- 
ing at Northwestern Memor- 
ial Hospital and a residency 
at the University of Illinois at 
Chicago Medical Center. 





Jared Allen, MD, PhD, 
received an undergraduate 
degree from Brigham Young 
University, a medical degree 
from the University of Cali- 
fornia, Los Angeles, and a 
doctoral degree from the 
University of California, San 
Diego. He completed additional 
training at LDS Hospital. 
Russell Allman, MD, 
received an undergraduate 
degree from Auburn Univer- 
sity and a medical degree 
from the University of 
Alabama. He completed 
additional training at Baptist 
Health System. 
Desi Dennis, MD, received 
an undergraduate degree from 
Southern Illinois University 
and a medical degree from 
Vanderbilt University. He 
completed additional train- 
ing at Saint Louis University. 
Jay Desai, MD, received an 
undergraduate from the Uni- 
versity of Mississippi and a 
medical degree from Emory 
University. He completed 
additional training at Brigham 
and Women's Hospital. 
Sara Dyrstad, MD, received 
an undergraduate degree 
from Augustana College and 
a medical degree from South- 
ern Illinois University. She 
completed additional train- 
ing at Southern Illinois 
School of Medicine and its 
affiliated hospitals. 
Amy Fowler, MD, PhD, 
received an undergraduate 
degree from South Dakota 
State University and a med- 
ical/doctoral degree from the 
University of Wisconsin. She 
completed additional train- 
ing at Gundersen Lutheran 
Medical Center. 
Michael Friedman, MD, 
received an undergraduate 
degree from Washington 
University in St. Louis and a 
medical degree from the Uni- 
versity of Iowa. He com- 
pleted additional training at 
St. Luke's Hospital. 
Amer Haque, MD, received 
an undergraduate degree 
from the University of Ken- 
tucky and a medical degree 
from the University of 
Louisville. He completed 
additional training at West 
Suburban Medical Center. 
Joseph Ippolito, MD, PhD, 
received an undergraduate 
degree from Cornell University 
and a medical/doctoral degree 
from Washington University 
in St. Louis. He completed 
additional training at St. 
John's Mercy Medical Center. 
Clinton Jokerst, MD, 
received an undergraduate 
degree and a medical degree 
from Saint Louis University. 
He completed additional 
training at St. John's Mercy 
Medical Center. 
Lauren Kim, MD, received 
an undergraduate degree 
from Harvard College and a 
medical degree from Wash- 
ington University in St. 
Louis., She completed addi- 
tional training at St. Mary's 
Health Center. 
Douglas Kitchin, MD, 
received an undergraduate 
degree from the University 
of Notre Dame and a medical 
degree from Indiana Univer- 
sity. He completed additional 
training at St. Luke's Medical 
Center. 
Jessica Lee, MD, received 
an undergraduate degree 
from Stanford University and 
a medical degree from Wash- 
ington University in St. Louis. 
She completed additional 
training at MacNeal Memor- 
ial Hospital. 
Luke Linscott, MD, 
received an undergraduate 
degree and a medical degree 
from the University of Utah. 
He completed additional 
training at Sacred Heart 
Medical Center. 
Nicholas Rhodes, MD, 
received an undergraduate 
degree from the University 
of Wisconsin and a medical 
degree from Washington 
University in St. Louis. He 
completed additional training 
at Barnes-Jewish Hospital. 
Gretchen Smith, MD, 
received an undergraduate 
degree and a medical degree 
from the University of Wash- 
ington. She completed addi- 
tional training at Virginia 
Mason Medical Center. 
Robert Stachecki, MD, 
received an undergraduate 
degree from the University 
of Notre Dame and a medical 
degree from Georgetown 
University. He completed 
additional training at St. 
Mary's Health Center. 
Motoyo Yano, MD, PhD, 
received an undergraduate 
degree from Tufts University 
and a medical/doctoral degree 
from Rosalind Franklin 
University of Medicine and 
Science. She completed addi- 
tional training at Advocate 





Joanna Fair, MD, PhD, 
received an undergraduate 
degree from Rice University, 
a doctoral degree from the 
University of Colorado, 
and a medical degree from 
Washington University in 
St. Louis. She completed a 
radiology residency at the 
University of New Mexico. 
Archana Kantawala, MD, 
completed premedical 
studies at Kirti M. Doongersee 
College and received a med- 
ical degree from Pravara 
Institute of Medical Sciences. 
She completed an internship 
and a residency at Seth 
Gordhandas Sunderas 
Medical College/King 
Edward Memorial Hospital. 
Marcus Kessler, MD, 
completed premedical stud- 
ies at and received a medical 
degree from the University 
of Cologne. He completed an 
internship at the Clinics of       , 
the City of Cologne; a diag- 
nostic radiology residency 
at Hospital Holweide; a 
pediatric radiology residency 
at Pediatric Hospital Amstei 
darner Strasse; and a pedi- 
atric radiology clinical 
fellowship at Mallinckrodt 
Institute of Radiology. 
Collins Liu, MD, received 
undergraduate degrees froi 
the University of California 
Berkeley and a medical degr 
from New York Medical Co 
lege. He completed an 
internship and a neurology 
residency at the University 
of Pittsburgh Medical Centi 
i 
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Jonathan Weiss, MD, 
received an undergraduate 
degree from Northwestern 
University and a medical 
degree from Indiana Univer- 
sity. He completed an intern- 
ship at St. Vincent Hospital 
and a diagnostic radiology 
residency at the Medical 
College of Wisconsin. 
GRANTS 
Kevin Black, MD, associate 
professor of psychiatry, of 
neurology, of radiology, and 
of anatomy and neurobiology, 
as site principal investigator, 
received a grant from 
Boehringer-Ingelheim 
Pharmaceuticals, Inc. for "A 
randomized, double-blind, 
placebo-controlled, flexible 
dose study to evaluate efficacy 
and safety of pramipexole IR 
(0.125-0.5mg/day) versus 
placebo for 6 weeks in children 
and adolescents (age 6-17 
inclusive) diagnosed with 
Tourette's Disorder according 
to DSM-IV criteria." Bradley 
Schlaggar, MD, PhD, assis- 
tant professor of neurology, 
of radiology, of pediatrics, 
and of neurobiology, is 
co-collaborator of the grant 
Thomas Conturo, MD, 
PhD, associate professor 
of radiology, of physics, and 
of biomedical engineering, 
as principal investigator, 
received a two-year grant in 
the amount of $119,963 from 
Autism Speaks to study 
"Analysis of brain 
microstructure in autism 
using diffusion MRI." Collab- 
orators are Erbil Akbudak, 
PhD, research assistant 
professor of radiology; 
Charles Smith, PhD, Univer- 
sity of Kentucky; and Nancy 
Minshew, MD, and Diane 
Williams, PhD, University 
of Pittsburgh. 
Tamara Hershey, PhD, 
assistant professor of psy- 
chiatry and of radiology, 
as principal investigator, 
received a $1.3 million grant 
from the National Institute 
of Mental Health, for 
"Mapping mood in the sub- 
thalamic nucleus in PD." 
Coinvestigators for the five- 
year grant are Kevin Black, 
MD, associate professor of 
psychiatry, of neurology, of 
radiology, and of anatomy 
and neurobiology; Tom 
Videen, PhD, research 
professor of neurology and 
of radiology; and Joel Perl- 
mutter, MD, professor of 
neurology, of radiology, and 
of physical therapy. Hershey 
also is principal investigator 
for a $1.1 million grant from 
the National Institute of Dia- 
betes and Digestive and Kid- 
ney Diseases to study 
"Glycemic control, brain 
structure and cognition in 
youth with T1DM." Coinves- 
tigators for the five-year 
grant are Kevin Black, MD; 
Neil White, MD, Department 
of Pediatrics; and Joshua 
Shimony, MD, PhD, assis- 
tant professor of radiology. 
Linda Larson-Prior, PhD, 
research associate professor 
of radiology, as imaging 
principal investigator, 
received a $76,660 grant 
from Cephalon, Inc. for a 
Phase IV Clinical Trial—"A 
randomized, double-blind, 
placebo-controlled, func- 
tional neuroimaging study of 
the effects of Armondafinil 
(200 mg/day) treatment on 
prefrontal cortical activation 
in patients with residual 
excessive sleepiness associ- 
ated with obstructive sleep 
apnea/hypopnea syndrome." 
Principal investigator for the 
one-year grant is Stephen 
Duntley, MD, Department of 
Neurology; coinvestigators 
are Beth Ward, MD, Depart- 
ment of Neurology; Ravi 
Aysola, MD, Department of 
Medicine; G. Warmouth, MD; 
Tonya Russell, MD, Depart- 
ment of Medicine; Amy 
Bertelson, PhD, Department 
of Psychology; Mehmet 
Dokucu, MD, Department 
of Psychiatry PhD; and Milan 
Anadkat, MD, Department 
of Medicine. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology, as principal inves- 
tigator of imaging core, 
received a four-year grant in 
the amount of $9,126 from 
the Medical College of 
Wisconsin, National Marrow 
Donor Program® to "deter- 
mine event-free survival at 
one year after unrelated 
donor hematopoieic stem 
cell transplantation using 
bone marrow or umbilical 
cord blood in patients with 
sickle cell disease." 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, as principal investi- 
gator, received a $3.2 million 
grant from the National Insti- 
tute of Neurological Disorders 
and Stroke for "Validation of 
neuroimaging biomarkers 
for nigrostriatal neurons." 
Coinvestigators for the five- 
year grant are Stephen 
Moerlein, PhD, associate 
professor of radiology and of 
biological chemistry; Tom 
Videen, PhD, research pro- 
fessor of neurology and of 
radiology; Morvarid Karimi, 
MD, Department of Neurology; 
and Joanne Mark ham, MS, 
research associate professor 
of radiology. 
David Reichert, PhD, assis- 
tant professor of radiology, 
received a two-year grant in 
the amount of $800,000 from 
the Department of Energy 
for "Microfluidic radiometal 
labeling systems for biomol- 
ecules." Co-collaborator for 
the grant is Paul Kenis, PhD, 
University of Illinois, 
Urbana-Champaign. 
Yoram Rudy, PhD, profes- 
sor of biomedical engineering, 
cell biology, and physiology, 
of medicine, and of pediatrics 
and research professor of 
radiology, as principal inves- 
tigator, received a four-year 
grant in the amount of $1.3 
million from the National 
Heart, Lung and Blood Insti- 
tute, for "Inverse and forward 
problems in electrocardiog- 
raphy." 
Jeffrey Zacks, MD, associ- 
ate professor of psychology 
and of radiology, as principal 
investigator, received a five- 
year grant in the amount of 
$1.5 million from the National 
Institutes of Health for 
"Encoding and remembering 
events across the lifespan." 
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APPOINTMENTS/ 
ELECTIONS 
Colin Derdeyn, MD, profes- 
sor of radiology and of neu- 
rology and neurological 
surgery, was appointed by 
the American Heart Associa- 
tion to a two-year term on the 
Research Committee and to a 
two-year term as chair of the 
Membership, Marketing, and 
Communications Committee. 
Bennett Greenspan, MD, 
instructor in radiology, was 
appointed to a three-year 
term as a member of the 
Practice Standards Commit- 
tee of the American College 
of Radiology, a two-year 
term on the Program Plan- 
ning Committee of the Asso- 
ciation of University 
Radiologists, and a one-year 
term on the Membership 
Committee of the Society of 
Nuclear Medicine. He was 
reappointed to a one-year 
term on the Nuclear Medi- 
cine Program Directors 
Committee of the Associa- 
tion of Program Directors in 
Radiology and to a three- 
year term on the Commis- 
sion on Accreditation of 
Medical Physics Educational 
Programs. 
Tamara Hershey, PhD, 
assistant professor of psychi- 
atry and of radiology, was 
appointed to a one-year term 
as secretary of the Washing- 
ton University School of 
Medicine Academic 
Women's Network Board. 
Linda Larson-Prior, PhD, 
research associate professor 
of radiology, was elected to 
a one-year term as pre-clini- 
cal counselor of the Wash- 
ington University School of 
Medicine Academic 
Women's Network Board. 
Robert McKinstry, MD, 
PhD, associate professor of 
radiology, was elected as a 
representative of the Wash- 
ington University School of 
Medicine Faculty Practice 
Plan to the Executive Com- 
mittee of the Faculty Council. 
HONORS/ 
AWARDS  
Louis Gilula, MD, 
professor of radiology, of 
orthopaedic surgery, and of 
plastic and reconstructive 
surgery, served as an exam- 
iner for the Radiology 
Boards, Louisville, 
Kentucky, May 31-June 3. 
Bennett Greenspan, MD, 
instructor in radiology, 
received the Academic 
Council of the Society of 
Nuclear Medicine's Distin- 
guished Service Award. 
LECTURES 
Tammie Benzinger, MD, 
PhD, assistant professor of 
radiology, spoke on "Clinical 
applications of diffusion ten- 
sor imaging" at the 6th MAG- 
NETOM World Summit, 
Munich, Germany, May 29- 
June 1. She presented 
"Advanced neuromagnetic 
resonance imaging: 3 Tesla 
in clinical practice" to the 
Central Illinois Radiological 
Society, Peoria, August 8. 
Kevin Black, MD, associate 
professor of psychiatry, of 
neurology, of radiology, and 
of anatomy and neurobiol- 
ogy, presented "Diagnosis 
and treatment of Tourette 
syndrome, 2008" at Neurol- 
ogy Grand Rounds, 
Louisiana State University 
Health Science Center, 
Shreveport, June 13. He 
spoke on "Quantitative phar- 
macodynamic imaging by a 
novel method" at the Organi- 
zation for Human Brain Map- 
ping 2008, Melbourne, 
Australia, June 15-19.- 
Colin Derdeyn, MD, profes- 
sor of radiology, of neurol- 
ogy, and of neurological 
surgery, spoke on "EC/IC 
Bypass/COSS Trial Update" 
at the Society for Neurolnt- 
erventional Surgery Annual 
Practicum, New Orleans, 
Louisiana, June 6. He pre- 
sented "Carotid artery steno- 
sis: Is there a future for 
neurosurgery in the treat- 
ment of disease?" at the 
Robert L. Grubb Jr., M.D. 
Research Symposium, 
St. Louis, Missouri, June 7. 
He spoke on "Acute stroke 
intervention" at the 21st 
Annual John H. Kendig Lec- 
ture, St. John's Mercy Hospi- 
tal, St. Louis, Missouri, July 16. 
Louis Gilula, MD, professor 
of radiology, of orthopaedic 
surgery, and of plastic and 
reconstructive surgery, as 
visiting professor, presented 
"Radiology Board review" at 
the Oregon Health and Sci- 
ence University, Portland, 
June 23. 
Tamara'Hershey, PhD, 
assistant professor of psychi- 
atry and of radiology, spoke 
on "Glycemic extremes and 
the developing human brain" 
at the Center for Neurobe- 
havioral Development, 
University of Minnesota, 
Minneapolis, August 5. 
Rebecca Hulett-Bowling, 
MD, assistant professor of 
radiology, presented "Inter- 
esting cases and unusual 
pediatric tumors" at the 
Pacific Coast Pediatric Radi- 
ology Association Annual 
Meeting, Napa, California, 
July 29-August 3. 
Linda Larson-Prior, PhD, 
research associate professor 
of radiology, spoke on "Neu- 
roimaging of human sleep" at 
the Sleep Research Society 
13th Annual Trainee Sympo- 
sium, Baltimore, Maryland, 
June 8. She presented "Phase 
synchrony analysis of net- 
work dynamics during task 
performance links EEG and 
BOLD" at the Organization 
for Human Brain Mapping 
Annual Meeting, Melbourne, 
Australia, June 15-19. 
Mark Mintun, MD, profes- 
sor of radiology, presented 
"FDG & amyloid PET: What 
information do these pro- 
vide?" at The Alzheimer's 
Disease Summit, sponsored 
by Mount Sinai School of 
Medicine and MBL Commu- 
nications, Washington, DC, 
May 3. He spoke on "Meta- 
bolic domains and neuronal 
activation" at the Gordon 
Research Conference on 
Brain Energy Metabolism and 
Blood Flow, Andover, New 
Hampshire, August 17-22. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, presented "Mentor- 
ing the mentors" and chaired 
the Biomarkers for PD Pro- 
gression session at the 
Parkinson Study Group 
Annual Meeting, San Diego, 
California, May 8 
James Quirk, PhD, 
research instructor in radio 
ogy, presented "Optimal 
sample parameter estimate 
from phased array coil dat; 
utilizing joint Bayesian 
analysis" at the 16"' Scientil 
Meeting of the Internationa 
Society for Magnetic Reso- 
nance in Medicine, Torontc 
Ontario, May 3-9. He spoke 
on "Models and application 
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of in vivo lung morphometry 
with hyperpolarized 3He 
MRI in a mild COPD popula- 
tion" at the 9"' International 
Bologna Conference on 
Magnetic Resonance in 
Porous Media, Cambridge, 
Massachusetts, July 13-17. 
Yoram Rudy, PhD, profes- 
sor of biomedical engineering, 
cell biology, and physiology, 
of medicine, and of pedi- 
atrics and research professor 
• of radiology, spoke on "The 
molecular basis for the clini- 
cal electrocardiogram— 
electrocardiographic imaging 
(ECGI): solving the electro- 
graphic inverse problem" 
and "Why do T-waves 
change?—Fundamental 
basis of the T-wave" at Heart 
Rhythm Society, 29th Annual 
Scientific Sessions, San 
Francisco, California, May 
16. He presented "Computa- 
tional biology and noninvasive 
imaging of cardiac arrhyth- 
mia," for the Department of 
Biomedical Engineering's 
Professor Samuel Sideman 
In Memoriam Lecture, and 
"Noninvasive electrocardio- 
graphic imaging (ECGI) of 
cardiac electrophysiology 
and arrhythmia" for the 
Cardiovascular Science 
Grand Rounds, Israel Insti- 
tute of Technology School 
of Medicine, Haifa. He 
spoke on "Noninvasive ECG 
imaging" at the World 
Congress in Cardiac Electro- 
physiology and Cardiac 
Techniques, Nice, France, 
June 19. 
Yvette Sheline, MD, 
professor of psychiatry, of 
radiology, and of neurology, 
presented "Support for the 
vascular depression hypoth- 
esis: neuropsychological and 
neuroimaging findings from 
a prospective treatment trial 
in LLD" at the American Psy- 
chiatric Association Annual 
Meeting, Washington, DC, 
May 3-8. 
Nasir Siddiqi, MD, assis- 
tant professor of radiology, 
spoke on "Arterial hepatic 
brachytherapy: VIR perspec- 
tive" at the New England 
Chapter of the Association 
of Physicists in Medicine 
Annual Meeting, Norwood, 
Massachusetts, June 18. 
Marilyn Siegel, MD, 
professor of radiology and 
of pediatrics, spoke on 
"Pediatric body MRI: 
advances and applications" 
at the 1st Educational Activity 
of the Pediatric MRI Center 
in Puerto Rico & Latin Amer- 
ica, San Juan, May 19. She 
spoke on "Cardiac CT in the 
pediatric patient: radiation 
considerations" at the 3rd 
Annual Scientific Meeting of 
the Society of Cardiovascu- 
lar Computed Tomography, 
Orlando, Florida, July 18. 
She presented "MDCT of 
adult congenital heart 
disease and MDCT of adult 
thoracic vascular anomalies" 
at the Summer Practicum of 
the Society of Computed 
Body Tomography and Mag- 
netic Resonance Imaging, 
Charleston, South Carolina, 
August 10 and 11. 
Jeffrey Zacks, MD, associ- 
ate professor of psychology 
and of radiology, presented 
"Event segmentation and 
memory" at the Eightieth 
Annual Meeting of the 
Midwestern Psychological 
Association, Chicago, Illi- 
nois, May 1-3. He spoke on 
"Perceptual segmentation of 
the behavior stream and the 
hierarchical organization of 
life events" at the SPARK 
Workshop on Habit and 
Routine, London, England, 
May 29 and 30. 
SYMPOSIA 
In this section ofFYI, only 
those faculty and staff who 
have Department of Radiol- 
ogy appointments are listed. 
SOCIETY OF NUCLEAR 
MEDICINE 
55th Annual Meeting 
New Orleans, Louisiana 
June 14-18, 2008 
Carolyn Anderson, PhD, 
"The importance of chelator 
for radiometal-based radio- 
pharmaceuticals in PET 
imaging"; "What is molecular 
imaging?" 
Bennett Greenspan, MD, 
"Radiotherapy response 
evaluation: When is the opti- 
mal time for PET imaging?"; 
"Ethics in research—respon- 
sibilities of the investigator." 
Robert Gropler, MD, 
"Where is cardiovascular 
molecular imaging going and 
when are we going to get 
there?" 
Aviv Hagooly; Raffaella 
Rossin; Monica Shokeen; 
Carolyn Anderson, PhD; 
Michael Welch, PhD, "Eval- 
uation of a RGD-dendrimer 
labeled with 7liBr in hindlimb 
ischemia mouse model." 
Zulfia Kisrieva-Ware, MD, 
PhD; Terry Sharp; Carmen 
Dence, MS; Andrew Cog- 
gan; Robert Gropler, MD; 
Pilar Herrero, MS, "Assess- 
ment of myocardial triglyc- 
eride turnover with PET and 
l-"C-palmitate." 
Hyeran Lee, PhD; Del- 
phine Chen, MD; Michael 
Welch, PhD; Robert Mach, 
PhD, "Fluorine-18 labeled 
PPARy antagonists for PET 
imaging studies." 
Yongjian Liu; Aviv 
Hagooly; Raffaella Rossin; 
Jinbin Xu; Karen Wooley, 
PhD; Michael Welch, PhD, 
"In vivo evaluation of 64Cu 
labeled PEGylated shell 
crosslinked nanoparticles 
(SCKs) as candidates for 
imaging and drug delivery." 
Jonathan McConathy, 
MD, PhD; Dong Zhou, 
PhD; Lynne Jones; Eliza- 
beth Griffin; Robert 
Mach, PhD, "Click synthesis 
and murine biodistribution 
of the radiolabeled amino 
acid [18F]AFETP." 
Mark Mintun, MD, "Emerg- 
ing CSF and blood biomarkers 
for AD and their likely impact 
on the role of imaging." 
Joel Perlmutter, MD, 
"DAT imaging does not pro- 
vide unique and clinically 
useful information." 
Raffaella Rossin; Aviv 
Hagooly; Michael Welch, 
PhD, "Characterization of 
wCU-labeled AMG 655 as a 
PET tracer for imaging 
Death Receptor 5 (DR5) in 
tumor." 
Henry Royal, MD, "Leader- 
ship success in academic 
nuclear medicine"; "ABNM 
perspective on MOC." 
Kooresh Shoghi, PhD; 
Robert Gropler, MD; 
Terry Sharp; Pilar Her- 
rero, MS; Nicole Fettig; 
Michael Welch, PhD, 
"Assessing the efficacy of 
anti-diabetic therapies on 
myocardial glucose utiliza- 
tion in an animal model of 
type 2 diabetes (T2D) with 
PET." 
Yi Su; Kooresh Shoghi, 
PhD, "Spatial constrained 
voxel-based kinetic analysis 
of small animal dynamic 
PET images with wavelet 
denoising." 
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Yuan-Chuan Tai, PhD; 
Heyu Wu; Tae Song; 
Joseph O'Sullivan, PhD; 
Sergey Komarov, "A high- 
resolution head insert device 
for a clinical PET/CT scanner." 
Zhude Tu, PhD; Robert 
Mach, PhD, "Evaluation of 
the putative dopamine D3 
PET tracer ["C]WC-10 in 
non-human primates." 
Zhude Tu, PhD; Jinbin Xu; 
Lynne Jones; Shihong Li; 
Robert Mach, PhD, 
"Radiosynthesis and in vivo 
evaluation of ["CJpapaverine 
as PDE10A PET tracer." 
Jerold Wallls, MD, "IHE: 
What is it and what is new?" 
Michael Welch, PhD, 
"Imaging tumor hypoxia with 
Cu-ATSM PET." 
Dong Zhou, PhD; Hyeran 
Lee, PhD; Justin Rothfuss; 
Delphine Chen, MD: Michael 
Welch, PhD; Robert Mach, 
PhD, "Synthesis, ,3F radiola- 
belling and in vivo biodistri- 
bution of 6-(2-fluoropropyl> 
4-methylpyridin-2-amine as a 
potential PET tracer." 
AMERICAN CHEMICAL 
SOCIETY 
236th National Meeting and 
Exposition 
Philadelphia, Pennsylvania 
August 17-21, 2008 
Samuel Achilefu, PhD; 
Mikhail Berezin, PhD; 
Walter Alters, DVM, PhD; 
Hyeran Lee, PhD; Mingfeng 
Bai, PhD; Sharon Bloch, 
PhD; Zongren Zhang, PhD; 
Yunpeng Ye, PhD; Ralph 
Nothdurft, MS; Joseph 
Culver, PhD, "Fluorescence 
lifetime imaging of tumors 
using near infrared fluores- 
cent molecular probes." 
m 
:'    & 
Samuel Achilefu, PhD; 
Yunpeng Ye, PhD; Zongren 
Zhang, PhD; Hyeran Lee, 
PhD; Jinda Fan, PhD; Kex- 
ian Liang; Mikhail Berezin, 
PhD; Philip Cheney; Barry 
Edwards, PhD, "Chemical 
and biochemical contrast 
strategies for optical imaging 
of molecular processes in vivo." 
Carolyn Anderson, PhD, 
"Career in molecular imaging 
research began with the 1984 
Summer School in Nuclear 
Chemistry." 
Carolyn Anderson, PhD; 
Michael Welch, PhD, "Grad- 
uate and undergraduate train- 
ing in imaging sciences at 
Washington University." 
Ashley Fiamengo; Yung- 
peng Ye, PhD; Samuel 
Achilefu, PhD; Carolyn 
Anderson, PhD, "Binding 
affinity and cellular internal- 
ization of avfi3 targeting lig- 
ands for molecular imaging 
of cancer and cardiovascular 
disease." 
Raffaella Rossin; Michael 
Welch, PhD; Karen Woo- 
ley, PhD, "Cell uptake and 
the dependency on surface 




Yvonne Taylor, PhD, a for- 
mer assistant professor in 
radiology, received Colgate 
University's Alumni Corpora- 
tion Humanitarian Award for 
her efforts to help improve 
education and living condi- 
tions in the African country 
of Kenya. Taylor joined the 
faculty of the Division of 
Radiation Oncology's Cancer 
Biology lab in 1986 and left 
in 1995 for a two-year stint 
as a science teacher in the 
Peace Corps. And she 
quickly fell in love with the 
Akamba people, who call her 
Mwende (or Loved One). 
She is the founder and CEO 
of One Heart with Africa 
Inc—an outgrowth of her 
dream to provide the 
Akamba with a clean and 
adequate resource for water 
(by spearheading the con- 
struction of 17 community- 
built, subsurface dams and 
water tanks along the Syuuni 
River) and to provide job 
Above, Left: Taylor (in white hat) is 
shown with the children of Kyamath- 
enge Primary School, where she is the 
administrator and principal and "chief 
cook and bottle washer." 
Above, Right: Taylor (right) and her 
adopted daughter Kanini Mutie, a 
Kenyan orphan who is now a student 
at the University of Nairobi. 
training for the Akamba 
children who cannot go to 
college (by offering compui 
training and establishing 
a technical institute that 
offers tailoring, dressmakii 
carpentry, and masonry 
classes). One Heart with 
Africa (online at http://on( 
heartwithafrica.org) also 
provides student sponsor- 
ships and promotes cultur; 
exchange. 
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FELLOWS AND RESIDENTS FOR 2008-2009 
Doctors Jeffrey Lin; Jonathan Sehy; Travis Hillen; Jonathan Baker; Jennifer Gould, diagnostic 
radiology residency program director; Gilbert Jost, director, Mallinckrodt Institute; Sara Rohr, diagnostic radiology chief 
resident; Meghan Lubner, diagnostic radiology chief resident; Jennifer Demertzis, diagnostic radiology chief resident; 
Robert McKinstry, research residency program director; Sanjiv Bajaj; Paul Holcombe; Alexander Ho. 
Doctors Cylen Javidan-Nejad, cardiothoracic imaging fellowship program director; Amy Oberhelman; 
Rex Parker; Carlos lima; Constantine Raptis; Tabassum Ahmed; Gilbert Cheung; Vincent Mellnick; Kevin Johnson; 
Calvin Barnes; Celine Buckley; Nicole Bolton; Robin Yang; Danielle Weems; Stanley Chan; Marcus Kessler; Michelle Miller- 
Thomas; Caitlin Lopez; Salil Patel; Susan Holley; Joseph Mettenberg; Patricia Richmond; Jennifer Salcman; Kristy Wolske; 
Norna Ludeman; Heather Tauschek; Jakob Schutz. 
Doctors Yasha Kadkhodayan; Carl Aschkenasi; Edward Hwang; Joseph Azok; Kelsey Morgan; Sushil 
Sonavane; Paul Frohnert; Alok Jaju; Prakash Masand; John Burkett; William Grande; Travis Henry; Lance Reinsmith; 
Kyle Shipley; Robert Cargile; Brandon Liu; Aaron Hendon; Omar Agosto; Ariel Kruger; Quan Vu; Yihua Zhou; Martin Reis; 
Thomas Watson; Ferenc Czeyda-Pommersheim; Srini Peddi; Alexander Sevrukov; Benjamin Pettus; Paolo Marciano; 
Jonathan McConathy; Vilaas Shetty. 
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